Ajanta Pharma Receives USFDA EIR for Paithan Plant, Inspection Closed with VAI Status Parthika Patel3 July 2026 12:00 AM ISTNew Delhi: Ajanta Pharma Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug...
Zydus Under USFDA Lens as Baddi Plant Receives Warning Letter Parthika Patel4 Jun 2026 10:04 PM ISTNew Delhi: Zydus Lifesciences has informed the stock exchanges that it has received a Warning Letter from the United States Food and Drug...
Granules Gets 4 USFDA Observations for US Facility sheeba farhat3 Jun 2026 7:38 PM ISTNew Delhi: Granules India Limited has announced that its wholly-owned subsidiary, Granules Pharmaceuticals, Inc. (GPI), located in Chantilly,...
Lupin Receives USFDA EIR for Ankleshwar Facility Following Pre-Approval Inspection sheeba farhat30 May 2026 7:10 PM ISTNew Delhi: Global pharmaceutical major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United...
Solara Active Pharma Gets EIR for Puducherry Ibuprofen Plant Post USFDA Inspection Parthika Patel29 April 2026 4:05 PM ISTNew Delhi: Solara Active Pharma Sciences Limited has announced the successful closure of a United States Food and Drug Administration (USFDA)...
Supriya Lifescience Secures USFDA EIR With VAI Status for Lote API Facility MD Bureau23 April 2026 11:00 AM ISTNew Delhi: Active pharmaceutical ingredients (API) manufacturer Supriya Lifescience on Wednesday announced that the USFDA has issued an Establishment...
Granules India Arm Gets USFDA VAI Status for Shamirpet Facility, No Action Required Parthika Patel1 April 2026 5:10 PM ISTNew Delhi: Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), has received a...
USFDA Closes Inspection of Dr Reddy's Srikakulam Facility with VAI Classification Parthika Patel7 March 2026 8:38 PM ISTNew Delhi: Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its...
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant Kajal Rajput27 Feb 2026 7:08 PM ISTNew Delhi: Drug maker Lupin on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its Goa-based...
Torrent Pharma Receives USFDA Clearance for Pithampur Facility with VAI Classification Farhat Nasim23 Nov 2024 12:49 PM ISTMumbai: Torrent Pharmaceuticals Limited has announced that the company received an Establishment Inspection Report (EIR) from the United States...
Lupin receives USFDA EIR for Vizag API Facility Ruchika Sharma14 May 2020 4:19 PM ISTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...
Dr Reddy's Labs gets USFDA EIR for Srikakulam formulations plant Ruchika Sharma14 May 2020 11:38 AM ISTHyderabad: Dr. Reddy's Laboratories Ltd on Wednesday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug...
